(Q80124152)
Statements
Relative efficiencies of physician/assessor global estimates and patient questionnaire measures are similar to or greater than joint counts to distinguish adalimumab from control treatments in rheumatoid arthritis clinical trials (English)
Theodore Pincus
Ingrid Amara
Oscar G Segurado
Martin Bergman
15 November 2007